PRAP1 and hepatocellular carcinoma: Remarkably, PRAP1 can reduce the expression of mitotic arrest deficient 1 (MAD1), a key constituent of SAC signaling, and suppress mitotic checkpoint signaling in hepatocellular carcinoma 25.